gp120/CD4

製品コード	製品名称	製品説明	文献中Selleckの製品使用例
A2101	Anti-mouse CD4-InVivo	Anti-mouse CD4 antibody(Clone:GK1.5) reacts with mouse CD4, which is a 55 kDa cell surface type I membrane glycoprotein. CD4 is a co-receptor of the T cell receptor (TCR) and assists the latter in communicating with antigen-presenting cells.	Signal Transduct Target Ther, 2025, 10(1):161 Nat Commun, 2025, 16(1):3546 Cell Rep Med, 2025, 6(3):101995
S2632	BMS-378806	BMS-378806 (BMS 806) selectively inhibits the binding of HIV-1 gp120 to the CD4 receptor with EC50 of 0.85-26.5 nM in virus.	Commun Biol, 2025, 8(1):442 Commun Biol, 2023, 6(1):535 J Virol, 2021, 95(24):e0052921
F2221^New	CD4 Antibody [F14D5]
S7220	Fostemsavir	Fostemsavir (BMS-663068, Rukobia), the phosphonooxymethyl prodrug of BMS626529, is an attachment inhibitor that targets HIV-1 gp120 and prevents its binding to CD4+ T cells with EC50 of < 10 nM.
S7487	YYA-021	YYA-021 is a CD4-mimic HIV entry inhibitor, competitively inhibiting the interaction between gp120 and CD4.
S2632	BMS-378806	BMS-378806 (BMS 806) selectively inhibits the binding of HIV-1 gp120 to the CD4 receptor with EC50 of 0.85-26.5 nM in virus.	Commun Biol, 2025, 8(1):442 Commun Biol, 2023, 6(1):535 J Virol, 2021, 95(24):e0052921
S7220	Fostemsavir	Fostemsavir (BMS-663068, Rukobia), the phosphonooxymethyl prodrug of BMS626529, is an attachment inhibitor that targets HIV-1 gp120 and prevents its binding to CD4+ T cells with EC50 of < 10 nM.
S7487	YYA-021	YYA-021 is a CD4-mimic HIV entry inhibitor, competitively inhibiting the interaction between gp120 and CD4.
A2101	Anti-mouse CD4-InVivo	Anti-mouse CD4 antibody(Clone:GK1.5) reacts with mouse CD4, which is a 55 kDa cell surface type I membrane glycoprotein. CD4 is a co-receptor of the T cell receptor (TCR) and assists the latter in communicating with antigen-presenting cells.	Signal Transduct Target Ther, 2025, 10(1):161 Nat Commun, 2025, 16(1):3546 Cell Rep Med, 2025, 6(3):101995
F2221^New	CD4 Antibody [F14D5]

gp120/CD4製品